Neuroimaging features of psilocybin-induced toxic-metabolic encephalopathy in an adolescent.
作者信息
Ho Clarice, Crawford John Ross
机构信息
School of Medicine, University of Nevada Reno School of Medicine, Reno, Nevada, USA.
Pediatrics, University of California Irvine, Irvine, California, USA
出版信息
BMJ Case Rep. 2024 Mar 5;17(3):e259721. doi: 10.1136/bcr-2024-259721.
Abstract
摘要
相似文献
1
Neuroimaging features of psilocybin-induced toxic-metabolic encephalopathy in an adolescent.
BMJ Case Rep. 2024 Mar 5;17(3):e259721. doi: 10.1136/bcr-2024-259721.
2
Metabolic Encephalopathy: Behind the Name.
Neurocrit Care. 2018 Dec;29(3):385-387. doi: 10.1007/s12028-017-0497-1.
3
The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience.
Netw Neurosci. 2024 Apr 1;8(1):203-225. doi: 10.1162/netn_a_00349. eCollection 2024.
4
The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.
Psychiatry Res. 2022 Jul;313:114577. doi: 10.1016/j.psychres.2022.114577. Epub 2022 Apr 26.
5
A neurologist's approach to delirium: diagnosis and management of toxic metabolic encephalopathies.
Eur J Intern Med. 2014 Feb;25(2):112-6. doi: 10.1016/j.ejim.2013.11.010. Epub 2013 Dec 10.
6
Toxic-metabolic encephalopathy in adults: Critical discussion and pragmatical diagnostic approach.
Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):93-104. doi: 10.1016/j.neurol.2021.11.007. Epub 2022 Jan 4.
7
Psychedelic drugs-a new era in
psychiatry?
.
Dialogues Clin Neurosci. 2019;21(2):139-147. doi: 10.31887/DCNS.2019.21.2/dnutt.
8
Neurobiological Correlates of Psilocybin Response in Depression.
Prim Care Companion CNS Disord. 2023 May 23;25(3):22r03419. doi: 10.4088/PCC.22r03419.
9
Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
Curr Top Med Chem. 2022;22(15):1250-1260. doi: 10.2174/1568026621666211201145800.
10
The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.
BMC Psychiatry. 2024 Apr 25;24(1):319. doi: 10.1186/s12888-024-05768-2.
本文引用的文献
1
Case report: Reversible splenial lesion syndrome caused by diquat poisoning.
Front Neurol. 2023 Aug 17;14:1178272. doi: 10.3389/fneur.2023.1178272. eCollection 2023.
2
Psilocybin's effects on cognition and creativity: A scoping review.
J Psychopharmacol. 2023 Jul;37(7):635-648. doi: 10.1177/02698811231179801. Epub 2023 Jul 3.
3
Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.
J Psychopharmacol. 2022 Aug;36(8):965-973. doi: 10.1177/02698811221084063. Epub 2022 Apr 7.
4
Cytotoxic Lesion of the Corpus Callosum in an Adolescent with Multisystem Inflammatory Syndrome and SARS-CoV-2 Infection.
AJNR Am J Neuroradiol. 2020 Nov;41(11):2017-2019. doi: 10.3174/ajnr.A6755. Epub 2020 Aug 20.
5
Lithium induced reversible Splenial lesion in neuroleptic malignant syndrome like symptoms: two case reports.
BMC Neurol. 2020 Apr 30;20(1):164. doi: 10.1186/s12883-020-01742-z.
6
Reversible splenial lesion syndrome: A differential diagnosis of corpus callosum lesions.
Neurol Psychiatry Brain Res. 2018 Dec;30:99-100. doi: 10.1016/j.npbr.2018.07.004. Epub 2018 Aug 2.
7
Psychedelics and Psychedelic-Assisted Psychotherapy.
Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26.
8
Imaging Patterns of Toxic and Metabolic Brain Disorders.
Radiographics. 2019 Oct;39(6):1672-1695. doi: 10.1148/rg.2019190016.
9
Toxic-Metabolic Neurologic Disorders in Children: A Neuroimaging Review.
J Neuroimaging. 2018 Nov;28(6):587-595. doi: 10.1111/jon.12551. Epub 2018 Jul 31.
10
Splenial Lesions of the Corpus Callosum: Disease Spectrum and MRI Findings.
Korean J Radiol. 2017 Jul-Aug;18(4):710-721. doi: 10.3348/kjr.2017.18.4.710. Epub 2017 May 19.
Zotero 插件